$1.77
-0.0308-1.71%
Last update: Nov 3, 7:36 PM
DataMEDS AI Inc (MEDS) Stock Price, Quote, News & History
MEDSNASDAQ
DataMEDS AI (MEDS) unit Corexa Health secures API supply for six peptides to begin dispensing in November 2026.
You can purchase shares of DataMEDS AI (NASDAQ:MEDS) through any online brokerage.
Other companies in DataMEDS AI’s space includes: McKesson Corp (NYSE:MCK), Cencora Inc (NYSE:COR), Cardinal Health Inc (NYSE:CAH), Henry Schein Inc (NASDAQ:HSIC) and AdaptHealth Corp (NASDAQ:AHCO).
There is no analysis for DataMEDS AI to provide a consensus price target.
The stock price for DataMEDS AI (NASDAQ: MEDS) is $1.7692 last updated November 3, 2026 at 7:36 PM EST.
There are no upcoming dividends for DataMEDS AI.
DataMEDS AI does not have any upcoming earnings scheduled.
There is no upcoming split for DataMEDS AI.
DataMEDS AI is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
DataMEDS AI Inc is a healthcare technology and pharmaceutical logistics company. The group simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. Its solutions provide a single, integrated platform for...
